MediFind

Find a Doctor

Liisa Volin

Huch Comprehensive Cancer Center
Female

Bio


Liisa Volin is in Helsinki, Finland. They have been an author on 133 peer reviewed articles in the past 15 years. Dr. Volin's top three areas of expertise are Graft Versus Host Disease, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloblastic Leukemia without Maturation.

Contact

Helsinki, FI

Latest Research


Latest Advance
Study
  • Condition: Acute Myeloid Leukemia
  • Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Treatment Used: Allogeneic Stem Cell Transplantation (allo-HSCT)
  • Number of Patients: 1134
  • Published —
This study tested the safety and efficacy of using allo-HSCT from a sibling or matched unrelated donor to treat patients with acute myeloid leukemia.
Latest Advance
Study
  • Condition: Myelofibrosis
  • Journal: Haematologica
  • Treatment Used: Allogeneic hematopoietic cell transplantation
  • Number of Patients: 1055
  • Published —
The study researched the long-term outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis.
Latest Advance
Study
  • Condition: T-Prolymphocytic Leukemia (T-PLL)
  • Journal: Bone marrow transplantation
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplant (Allo-SCT)
  • Number of Patients: 37
  • Published —
This study tested the safety and efficacy of using allo-SCT to treat patients with T-PLL.
Latest Advance
Study
  • Condition: Adverse Karyotype Acute Myeloid Leukemia in First Complete Remission
  • Journal: American journal of hematology
  • Treatment Used: Haploidentical Versus 10/10 Versus 9/10 Unrelated Donor Transplantation
  • Number of Patients: 630
  • Published —
The purpose of the study was to analyze outcomes of patients undergoing T-cell repleted Haploidentical, 10/10 HLA-matched unrelated donor, and 9/10 unrelated donor hematopoietic stem cell transplantation for the treatment of adverse karyotype acute myeloid leukemia in first remission.
Latest Advance
Study
  • Condition: Acute Graft-Versus-Host Disease
  • Journal: Transfusion
  • Treatment Used: Extracorporeal Photopheresis
  • Number of Patients: 52
  • Published —
This study tested the safety and efficacy of using extracorporeal photopheresis to treat patients with acute graft-versus-host disease.
Latest Advance
Study
  • Condition: Acute Myeloid Leukemia with inv(3)(q21;q26.2)/t(3;3)(q21;q26.2) (3q26 AML)
  • Journal: Bone marrow transplantation
  • Treatment Used: Allogeneic Stem Cell Transplantation (alloHSCT)
  • Number of Patients: 53
  • Published —
This study evaluated allogeneic stem cell transplantation (alloHSCT) in the treatment of 3q26 acute myeloid leukemia (AML).
Latest Advance
Study
  • Condition: Ph-Negative Acute Lymphoblastic Leukemia
  • Journal: American journal of hematology
  • Treatment Used: Cyclophosphamide or Etoposide with Total Body Irradiation to condition for Allogeneic Stem Cell Transplant
  • Number of Patients: 1498
  • Published —
This study compared the clinical outcome of using cyclophosphamide or etoposide with total body irradiation in order to condition patients for allogeneic stem cell transplantation to treat Ph-negative acute lymphoblastic leukemia.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Helsinki, FI

Insurance

Contact them to find out if they accept your insurance plan.